Page 183 - product-manual
P. 183
TM/MC
REFERENCES
Alam M, Pongprutthipan M. (Eds). (2010). Body Rejuvenation. New York (USA): Springer.
Baisse E, Piotrowski B, Piatoni P, Brunel G. (2003). Action of hyaluronic acid on the wound healing process following extraction. Clinical Pathology. Accessed: December 3,
2011. Available at: http://www.your-dent.co.il/UserFiles/Image/pdf/profBRUNEL.pdf
Becker LC, Bergfeld WF, Belsito DV, et al. (2009). Final report of the safety assessment of hyaluronic acid, potassium hyaluronate, and sodium hyaluronate. International
Journal of Toxicology. 28:5-67.
Chen WYJ, Abatangelo G. (1999). Wound repair and regeneration. The International Journal of Tissue Repair and Regeneration. 7:79-89.
Chevalier X. (2011). Mechanisms of action of hyaluronic acid. IBSA-Genevrier. Launch Satellite Symposium. In: Hyaluronic Acid: A suitable option to improve joint mobility
for patient well-being. Creteil (France).
Comper WD. (1996). Extracellular Matrix Volume 2. Molecular Components and Interactions. Amsterdam. Harwood Academic Publishers.
Edwards PC, Fantasia JE. (2007). Review of long-term adverse effects associated with the use of chemically-modified animal and non-animal source hyaluronic acid dermal
fillers. Clinical Interventions in Aging. 2:509-19.
Frasher, JRE, Laurent TC, Laurent UBG. (1997). Hyaluronan: its nature, distribution, functions and turnover. Journal of Internal Medicine. 242:27-33.
Martindale. (1996). The Extra Pharmacopoeia. Thirty-first Edition. The Royal Pharmaceutical Society. Page 1754.
Saari H, Konttinen YT, Friman C, Sorsa T. (1993). Differential effects of reactive oxygen species on native synovial fluid and purified human umbilical cord hyaluronate.
Inflammation. 17:403-415.
Tsukasa M. (2006). Mechanism of Action of Hyaluronic Acid. Journal of Joint Surgery. 25:489-491.
Vedamurthy M. (2004). Soft Tissue Augmentation – Use of Hyaluronic Acid as dermal filler. Indian Journal of Dermatology, Venereology and
Leprology. 70:383-7.
SynoForte-VM ™
4 | SynoFortev -VM TM